Crypto News: Ripple to Ramp Up Investments; Mastercard’s Blockchain Hiring Spree

Cryptocurrency giant Ripple is on the hunt for more deals. CEO Brad Garlinghouse told Yahoo! Finance UK that the company is considering multiple …

The crypto industry is a dynamic landscape. New alliances are constantly being formed as companies seek to gain ground on the competition. But allies can also become adversaries, and businesses must invest in the technology and talent that can help them adapt to new developments and shifting trends.

In recent weeks, several powerful enterprises have made it known that they plan to invest aggressively to strengthen their competitive position within the rapidly expanding blockchain industry. In this regard, the following announcements are particularly noteworthy.

A compass pointing towards the word invest

Image source: Getty Images.

Ripple’s growth-through-acquisition strategy

Cryptocurrency giant Ripple is on the hunt for more deals. CEO Brad Garlinghouse told Yahoo! Finance UK that the company is considering multiple potential acquisitions and investment opportunities as a means to boost the usage of its payments technology and XRP cryptocurrency token.

“Anything we can do to accelerate our growth and give us more capabilities that serve customer needs is a good place to be,” Garlinghouse said.

Ripple is flush with cash from sales of its XRP tokens to exchanges and other financial institutions. Ripple still owns more than half of the total supply of the international payments-focused cryptocurrency — a stake worth approximately $15 billion. Most of the tokens are locked in escrow, but Ripple sells some on a regular basis, including more than $250 million worth of XRP in the second quarter.

In June, Ripple invested $30 million in MoneyGram International(NASDAQ:MGI) in exchange for a 10% stake in the money-transfer company, along with an option to invest another $20 million in the future. As part of the deal, Moneygram agreed to use Ripple’s xRapid product and XRP cryptocurrency to facilitate international payments among its customers.

Garlinghouse said Ripple has invested approximately $500 million in blockchain-related projects — and that the company is looking for more deals that could help to further increase adoption of its cryptocurrency technology.

“We’re in a very strong position, our business is growing strongly, we have a strong balance sheet, and I intend to press our advantage,” Garlinghouse said.

A person pointing to a digital button labeled now hiring

Image source: Getty Images.

Mastercard’s hiring spree

Mastercard(NYSE:MA) wants to beef up its blockchain expertise. The Block noted that the digital-payments titan listed several job openings on its website related to blockchain project management. The job listings suggest the company may be gearing up to compete in the cryptocurrency wallet space. A cryptocurrency wallet is a software program that allows users to send and receive digital currency.

The blockchain-focused hirings could also be related to Facebook‘s (NASDAQ:FB)Libra digital currency project. As one of the project’s founding members, Mastercard can build applications for the Libra platform. Yet Facebook’s plans to develop Libra into a global payment system also make it a potential competitor to Mastercard’s credit card network.

With Libra and other cryptocurrency-based payment platforms representing both opportunities and threats, Mastercard is likely to invest considerable resources into bolstering its blockchain capabilities in the years ahead.

Related Posts:

  • No Related Posts

Ripple-Promoted Token Price Analysis XRP / USD: On Sale

Ripple is back under selling pressure on Wednesday after the third largest cryptocurrency was swiftly rejected from the $0.2930 level earlier this week.
  • Ripple is moving back towards the $0.2500 level after the third largest cryptocurrency suffered a technical rejection from the $0.2930 level
  • Ripple buyers need to form a bullish double-bottom or a further decline towards the $0.2000 level is possible.

Ripple is back under selling pressure on Wednesday after the third largest cryptocurrency was swiftly rejected from the $0.2930 level earlier this week. The XRP / USD pair’s technical outlook worsened last week after a major bearish breakout below the $0.3000 level, which prompted a rapid technical sell-off towards the $0.2380 level.

Going forward, buyers need to defend the key $0.2500 level and form a bullish double-bottom pattern formation across the lower time frames to encourage short-term technical buying. Both the four-hour and daily time frames are showing that bulls need to move price above the $0.3050 to $0.3060 level to further stabilize the short-term sentiment towards the XRP / USD pair.

Currently there are few reasons to be bullish towards the XRP / USD pair until price moves above the $0.3050 to $0.3060 level as the overall short and medium-term trend for Ripple is overwhelmingly bearish. The $0.2380 level is key the area that sellers may soon attempt to break for an even greater decline towards the $0.2000 level.

SIMETRI ResearchSIMETRI Research

A bearish death-cross is also underway on the daily time frame, while the RSI indicator on the daily time frame is still not oversold. These indicators are highlighting that the decline currently shows few signs of stopping, despite the XRP / USD suffering a thirteen percent decline in just over one week.

According to the latest sentiment data from TheTIE.io, the short-term sentiment towards Ripple is surprisingly bullish, at 57.00 %, while the overall long-term sentiment towards the cryptocurrency is bearish, at 38.17%.

XRP H4 Chart August 21 by TradingViewXRP H4 Chart August 21 by TradingView
XRP / USD H4 Chart by TradingView


Upside Potential

The four-hour time frame is showing that if bulls must break above rising trendline resistance from the $0.2950 level for further bullish advancement towards the $0.3050 area. The main short-term resistance area above the $0.3050 level is currently found at the August 5th swing-high, just below the $0.3300 level.

The daily time frame highlights the recent bearish breakout from the large triangle pattern has changed the technical landscape. Key technical resistance on the daily time frame comes from the psychological $0.3000 level and the pair’s trend-defining 200-day moving average, at $0.3200.

XRP Daily Chart August 21 by TradingViewXRP Daily Chart August 21 by TradingView
XRP / USD Daily Chart by TradingView


Downside Potential

The downside potential for the XRP / USD pair is unlikely to extend to far beyond the $0.2000 level if we do see the monthly trading low broken over the coming sessions. Selling upside technical corrections is still preferred as a bearish death-cross is currently underway, and the XRP / USD pair is still creating bearish lower highs.

The four-hour time frame shows that the XRP / USD pair has limited technical support under the $0.2500 level, while the daily time frame shows that the November 2017 trading low, around the $0.1890 level is the strongest form of support below the $0.2000 level.


Summary

Ripple is currently technically bearish across all time horizons, highlighting that the XRP / USD remains a strong sell until price recovers above the $0.3050 to $0.3060 levels.

Overall, a decline under the $0.2380 suggest that an even deeper fall towards the $0.2000 level appears increasingly likely.

Find out more about Ripple in our coin guide.

A deeper look into the merits of the project can be found in our DARE.

Stay up-up-to-date with our live BlockTV feed!
They even took out the ads, to show their support for our cause!

XRP Chart

Related Posts:

  • No Related Posts

Dallas Mavericks Accept Bitcoin for Tickets and Merchandise

… Mavericks-branded merchandise in the team’s online store. The Bitcoin payments will be offered through cryptocurrency payment processor BitPay.

NBA franchise Dallas Mavericks has introducedBitcoin as a payment option for purchasing game tickets and Mavericks-branded merchandise in the team’s online store. The Bitcoin payments will be offered through cryptocurrency payment processor BitPay.

BitPay CEO Stephen Pair commented:

“The Dallas Mavericks have been an outspoken advocate for Bitcoin, opening up opportunities for the team as it starts to accept Bitcoin for ticket sales and merchandise.”

Interestingly enough, Dallas Mavericks owner Mark Cuban does not seem to be much of a fan of Bitcoin as an investment. In an interview with Kitco News that first aired in April of 2018, Cuban compared Bitcoin with gold, saying that they are the “same thing”.

While this would be seen by many Bitcoin advocates as a stamp of approval, Cuban proceeded to slam gold as an investment. He did note, however, that Bitcoin’s finite supply was an advantage compared to gold. According to Breaker, Cuban has also made some crypto-related investments, namely in the VC fund 1confirmation and Unikrn. He has also praised the future potential of blockchain technology.

NBA and crypto

With the move to accept Bitcoin payments, the Mavs have become the second NBA franchise to accept cryptocurrency – the first was the Sacramento Kings, which started accepting Bitcoin already in early 2014. The Kings expanded their involvement with crypto later on, with the franchise announcing in 2018 that it would be mining Ethereum in their arena and using the proceeds for charity.

We’re slowly seeing connections being made between the world of blockchain and the NBA. For example, creators of popular game Cryptokitties have partnered with the league to create a blockchain-based game where players can collect and trade highlight plays from their favorite NBA stars.

Related Posts:

  • No Related Posts

Aurora Cannabis Inc. (ACB) EPS Estimated At $-0.02; Enzo Biochem (ENZ) Shorts Decreased By …

Enzo Biochem Inc (NYSE:ENZ) had a decrease of 18.66% in short interest. ENZ’s SI was 1.02 million shares in August as released by FINRA. Its down …

Enzo Biochem Inc (NYSE:ENZ) had a decrease of 18.66% in short interest. ENZ’s SI was 1.02 million shares in August as released by FINRA. Its down 18.66% from 1.25M shares previously. With 236,400 avg volume, 4 days are for Enzo Biochem Inc (NYSE:ENZ)’s short sellers to cover ENZ’s short positions. The SI to Enzo Biochem Inc’s float is 2.33%. The stock increased 0.96% or $0.03 during the last trading session, reaching $3.14. About 86,670 shares traded. Enzo Biochem, Inc. (NYSE:ENZ) has declined 9.49% since August 21, 2018 and is downtrending. It has underperformed by 9.49% the S&P500. Some Historical ENZ News: 24/04/2018 – ENZO: HOLOGIC CHALLENGING ENZO PATENT IN INFRINGEMENT CASE; 12/03/2018 – ENZO BIOCHEM INC – QTRLY SHR LOSS $0.02; 24/04/2018 – ENZO BIOCHEM SAYS BOARD DENIED HOLOGIC PETITION ON PATENT CLAIM; 12/03/2018 Enzo Biochem 2Q Loss/Shr 2c; 24/04/2018 – CORRECT: HOLX SOUGHT TO CHALLENGE ENZO PATENT IN DELAWARE CASE; 12/03/2018 – ENZO BIOCHEM 2Q ADJ LOSS/SHR 4.0C; 24/04/2018 – ENZO BIOCHEM INC – PATENT TRIAL AND APPEAL BOARD HAS DENIED A PETITION FILED BY HOLOGIC FOR INTER PARTES REVIEW; 24/04/2018 – ENZO: PATENT TRIAL & APPEAL BOARD DENIES HOLOGIC PETITION; 19/04/2018 – DJ Enzo Biochem Inc, Inst Holders, 1Q 2018 (ENZ); 24/04/2018 – Patent Trial and Appeal Board Denies Hologic Challenge to Enzo Biochem Patent lnvolved in Delaware Infringement Case

Analysts expect Aurora Cannabis Inc. (NYSE:ACB) to report $-0.02 EPS on September, 24.They anticipate $0.15 EPS change or 115.38% from last quarter’s $0.13 EPS. After having $-0.08 EPS previously, Aurora Cannabis Inc.’s analysts see -75.00% EPS growth. The stock increased 1.54% or $0.09 during the last trading session, reaching $5.93. About 12.37 million shares traded or 4.34% up from the average. Aurora Cannabis Inc. (NYSE:ACB) has risen 25.23% since August 21, 2018 and is uptrending. It has outperformed by 25.23% the S&P500.

Aurora Cannabis Inc. produces and distributes medical cannabis products. The company has market cap of $6.04 billion. It is vertically integrated and horizontally diversified across various divisions of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. It has a 27.45 P/E ratio. The company’s products consist of dried cannabis and cannabis oil; CanniMed vegan capsules; and hemp products, as well as sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products.

More notable recent Aurora Cannabis Inc. (NYSE:ACB) news were published by: Investorplace.com which released: “How to Position Smartly in Aurora Cannabis Stock – Investorplace.com” on August 19, 2019, also Investorplace.com with their article: “ACB Will Not Benefit From The Growth of Aurora Cannabis, Yet – Investorplace.com” published on August 15, 2019, Investorplace.com published: “A $3 Opportunity in Aurora Cannabis Stock – Investorplace.com” on August 12, 2019. More interesting news about Aurora Cannabis Inc. (NYSE:ACB) were released by: Seekingalpha.com and their article: “Aurora Cannabis: Conflicting Moment – Seeking Alpha” published on August 08, 2019 as well as Fool.com‘s news article titled: “Weekly Cannabis Stock News: Canopy Growth’s Ugly Q1 – The Motley Fool” with publication date: August 17, 2019.

Investors sentiment increased to 1.25 in 2019 Q1. Its up 0.60, from 0.65 in 2018Q4. It is positive, as 10 investors sold Enzo Biochem, Inc. shares while 18 reduced holdings. 11 funds opened positions while 24 raised stakes. 27.19 million shares or 1.04% more from 26.91 million shares in 2018Q4 were reported. The Illinois-based Citadel has invested 0% in Enzo Biochem, Inc. (NYSE:ENZ). Harbert Fund Advsrs reported 8.14% stake. Renaissance Technology Limited Company has 0.01% invested in Enzo Biochem, Inc. (NYSE:ENZ). Citigroup Inc owns 0% invested in Enzo Biochem, Inc. (NYSE:ENZ) for 12,085 shares. Bnp Paribas Arbitrage Sa invested in 0% or 9,242 shares. Amer Intll Gru holds 28,084 shares. Neuberger Berman Group Limited Co holds 22,613 shares. State Street Corporation holds 0% of its portfolio in Enzo Biochem, Inc. (NYSE:ENZ) for 742,444 shares. Federated Invsts Pa owns 0% invested in Enzo Biochem, Inc. (NYSE:ENZ) for 305 shares. Focused Wealth Mngmt has invested 0% in Enzo Biochem, Inc. (NYSE:ENZ). Comml Bank Of New York Mellon Corp, a New York-based fund reported 223,892 shares. Financial Bank Of America Corp De invested in 0% or 51,071 shares. Advisory Service Ntwk Lc reported 500 shares or 0% of all its holdings. Moreover, Ameritas Inv Prtnrs has 0% invested in Enzo Biochem, Inc. (NYSE:ENZ) for 3,092 shares. Moreover, Credit Suisse Ag has 0% invested in Enzo Biochem, Inc. (NYSE:ENZ) for 10,129 shares.

Enzo Biochem, Inc., an integrated diagnostic bioscience company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company has market cap of $149.33 million. The firm operates in three divisions: Clinical Labs, Life Sciences, and Therapeutics. It has a 69.78 P/E ratio. The Clinical Labs segment provides routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication levels, and search for an otherwise undiagnosed condition.

More notable recent Enzo Biochem, Inc. (NYSE:ENZ) news were published by: Finance.Yahoo.com which released: “Is Enzo Biochem (NYSE:ENZ) Using Debt In A Risky Way? – Yahoo Finance” on August 15, 2019, also Streetinsider.com with their article: “Enzo Biochem (ENZ) Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology – StreetInsider.com” published on August 05, 2019, Seekingalpha.com published: “Pluristem Therapeutics and EDAP TMS among healthcare gainers; Align Technology among losers – Seeking Alpha” on July 25, 2019. More interesting news about Enzo Biochem, Inc. (NYSE:ENZ) were released by: Finance.Yahoo.com and their article: “What Kind Of Share Price Volatility Should You Expect For Enzo Biochem, Inc. (NYSE:ENZ)? – Yahoo Finance” published on June 11, 2019 as well as Seekingalpha.com‘s news article titled: “Enzo Biochem +23.5% as holder raises stake, presses strategic review – Seeking Alpha” with publication date: March 26, 2019.

Enzo Biochem, Inc. (NYSE:ENZ) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts

3M Co (MMM) Stake Maintained by Bollard Group Llc; Exact Sciences (EXAS) Shareholder Nine …

… Fills lmmense Auscultation Quality Gap for Clinicians Treating Patients in lsolation; 04/04/2018 – C3 IOT ANNOUNCED MULTI-YEAR AGREEMENT …

Exact Sciences Corporation (NASDAQ:EXAS) Logo

Bollard Group Llc increased its stake in 3M Co (MMM) by 216.61% based on its latest 2019Q1 regulatory filing with the SEC. Bollard Group Llc bought 19,153 shares as the company’s stock declined 6.10% . The hedge fund held 27,995 shares of the medical and dental instruments company at the end of 2019Q1, valued at $5.82M, up from 8,842 at the end of the previous reported quarter. Bollard Group Llc who had been investing in 3M Co for a number of months, seems to be bullish on the $92.63B market cap company. The stock decreased 1.19% or $1.94 during the last trading session, reaching $161.01. About 2.02 million shares traded. 3M Company (NYSE:MMM) has declined 14.82% since August 21, 2018 and is downtrending. It has underperformed by 14.82% the S&P500. Some Historical MMM News: 24/04/2018 – 3M CO – IN QTR, RESOLVED A PREVIOUSLY DISCLOSED LAWSUIT WITH THE STATE OF MINNESOTA AND RECORDED A PRE-TAX CHARGE OF $897 MILLION; 13/03/2018 – SPAIN 3M BILLS BID-TO-COVER 5.59 VS 6.15 AT FEB. 20 AUCTION; 30/05/2018 – 3M INDIA 4Q NET INCOME 930.5M RUPEES VERSUS 903.9M RUPEES; 30/05/2018 – 3M INDIA LTD TMIN.NS – APPROVES PROPOSAL FOR INVESTMENT IN 3M ELECTRO & COMMUNICATION INDIA FOR AMOUNT NOT EXCEEDING 5.90 BLN RUPEES; 09/05/2018 – 3M NAMES MOJDEH POUL EVP, SAFETY-GRAPHICS GROUP; 24/04/2018 – 3M sinks 8%, eyes biggest drop since 2006; 05/03/2018 – 3M: Roman Succeeds Thulin as CEO Effective July 1; 23/04/2018 – China 3M Shibor Yield at 4.40% by End-2Q18 (Survey); 03/05/2018 – 3M’s New Single-Patient Stethoscope Fills lmmense Auscultation Quality Gap for Clinicians Treating Patients in lsolation; 04/04/2018 – C3 IOT ANNOUNCED MULTI-YEAR AGREEMENT WITH 3M TO PROVIDE C3 IOT Al AND IOT SOFTWARE PLATFORM TO SUPPORT 3M’S DIGITAL TRANSFORMATION

Nine Masts Capital Ltd decreased its stake in Exact Sciences Corp (EXAS) by 89.47% based on its latest 2019Q1 regulatory filing with the SEC. Nine Masts Capital Ltd sold 35,786 shares as the company’s stock rose 18.40% . The hedge fund held 4,214 shares of the commercial physical & biological resarch company at the end of 2019Q1, valued at $365,000, down from 40,000 at the end of the previous reported quarter. Nine Masts Capital Ltd who had been investing in Exact Sciences Corp for a number of months, seems to be less bullish one the $15.25 billion market cap company. The stock increased 1.10% or $1.3 during the last trading session, reaching $119.46. About 876,875 shares traded. Exact Sciences Corporation (NASDAQ:EXAS) has risen 100.54% since August 21, 2018 and is uptrending. It has outperformed by 100.54% the S&P500. Some Historical EXAS News: 30/05/2018 – American Cancer Society recommends earlier colorectal cancer screening; 23/04/2018 – DJ Exact Sciences Corporation, Inst Holders, 1Q 2018 (EXAS); 26/04/2018 – EXACT Sciences 1Q Loss $39.4M; 26/04/2018 – EXACT Sciences 1Q Rev $90.3M; 26/04/2018 – EXACT SCIENCES CORP EXAS.O SEES FY 2018 REVENUE $420 MLN TO $430 MLN; 06/03/2018 – Exact Sciences Names Paul Limburg Co-Chief Medical Officer; 19/03/2018 – Harry Connick, Jr. and Wife and Cancer Survivor Jill Connick Team Up to Urge People 50 and Older to Get Screened for Colon Cancer; 26/04/2018 – Exact Sciences Closes Above 50-Day Moving Average: Technicals

Investors sentiment increased to 1.29 in 2019 Q1. Its up 0.49, from 0.8 in 2018Q4. It is positive, as 30 investors sold EXAS shares while 103 reduced holdings. 73 funds opened positions while 99 raised stakes. 126.90 million shares or 19.88% more from 105.85 million shares in 2018Q4 were reported. Jane Street Grp Ltd Liability Corp has invested 0.01% in Exact Sciences Corporation (NASDAQ:EXAS). Sigma Planning, a Michigan-based fund reported 4,112 shares. Neuberger Berman Grp Ltd Com invested in 0.02% or 199,806 shares. Moreover, Mackay Shields Limited Liability has 0.24% invested in Exact Sciences Corporation (NASDAQ:EXAS). Biondo Llc holds 196,620 shares or 4.27% of its portfolio. Next Century Growth Invsts Ltd Liability Co accumulated 78,333 shares or 0.91% of the stock. Synovus Finance stated it has 0% in Exact Sciences Corporation (NASDAQ:EXAS). Tortoise Management Lc reported 628 shares stake. Metropolitan Life Ins accumulated 4,573 shares or 0% of the stock. Invesco Ltd has invested 0.01% in Exact Sciences Corporation (NASDAQ:EXAS). Rock Springs Capital Mgmt Limited Partnership has 1.33% invested in Exact Sciences Corporation (NASDAQ:EXAS). Credit Suisse Ag invested in 0.05% or 681,220 shares. Northern Trust has 608,619 shares. 754,405 are owned by Charles Schwab Invest. Northeast Mngmt has 45,047 shares for 0.33% of their portfolio.

Nine Masts Capital Ltd, which manages about $320.80M US Long portfolio, upped its stake in Iqiyi Inc by 58,400 shares to 89,300 shares, valued at $2.14 million in 2019Q1, according to the filing. It also increased its holding in Ctrip Com Intl Ltd (Call) (NASDAQ:CTRP) by 89,300 shares in the quarter, for a total of 160,000 shares, and has risen its stake in Alphabet Inc.

More notable recent Exact Sciences Corporation (NASDAQ:EXAS) news were published by: Nasdaq.com which released: “Notable Wednesday Option Activity: EXAS, GILD, PSTG – Nasdaq” on June 12, 2019, also Nasdaq.com with their article: “Could Exact Sciences Be a Millionaire-Maker Stock? – Nasdaq” published on February 17, 2019, Finance.Yahoo.com published: “Hedge Funds Have Never Been More Bullish On EXACT Sciences Corporation (EXAS) – Yahoo Finance” on June 17, 2019. More interesting news about Exact Sciences Corporation (NASDAQ:EXAS) were released by: Benzinga.com and their article: “A Look At Benzinga Pro’s Most-Searched Tickers For July 30, 2019 – Benzinga” published on July 30, 2019 as well as Nasdaq.com‘s news article titled: “Better Buy: Exact Sciences vs. Illumina – Nasdaq” with publication date: March 17, 2019.

Investors sentiment increased to 0.98 in 2019 Q1. Its up 0.18, from 0.8 in 2018Q4. It improved, as 55 investors sold MMM shares while 546 reduced holdings. 135 funds opened positions while 452 raised stakes. 375.82 million shares or 5.73% less from 398.67 million shares in 2018Q4 were reported. Gardner Russo Gardner Ltd Limited Liability Company reported 1,140 shares. Summit Financial Strategies owns 1,329 shares. Ifrah Svcs Incorporated invested in 0.1% or 1,231 shares. Community Natl Bank Na owns 23,443 shares for 0.98% of their portfolio. Sigma Invest Counselors owns 0.47% invested in 3M Company (NYSE:MMM) for 18,358 shares. Reynders Mcveigh Cap Mgmt Ltd Liability Company has 27,696 shares for 0.64% of their portfolio. Fayez Sarofim invested in 81,494 shares. Columbia Asset holds 39,473 shares or 2.19% of its portfolio. Congress Asset Mgmt Ma, Massachusetts-based fund reported 31,563 shares. 11,157 were accumulated by First Savings Bank. Schwartz Counsel Incorporated reported 1.69% stake. Marietta Partners Ltd Liability Co reported 13,452 shares or 0.88% of all its holdings. Lee Danner And Bass holds 0.25% or 10,882 shares. Reliance Company Of Delaware reported 0.25% in 3M Company (NYSE:MMM). Gamco Inc Et Al holds 7,637 shares or 0.01% of its portfolio.

Since May 9, 2019, it had 1 insider buy, and 0 selling transactions for $176,260 activity.

More notable recent 3M Company (NYSE:MMM) news were published by: Seekingalpha.com which released: “3M Q2 2019 Earnings Preview – Seeking Alpha” on July 24, 2019, also Finance.Yahoo.com with their article: “Is 3M Company (MMM) A Good Stock To Buy? – Yahoo Finance” published on June 11, 2019, Investorplace.com published: “The 3% Yield for 3M Stock Makes It an Attractive Value Buy – Investorplace.com” on July 23, 2019. More interesting news about 3M Company (NYSE:MMM) were released by: Seekingalpha.com and their article: “3M gets 5,000 surgical warming lawsuits dismissed – Seeking Alpha” published on August 01, 2019 as well as Globenewswire.com‘s news article titled: “MMM Shareholder Alert: Hagens Berman Reminds 3M Shareholders of Firm’s Investigation of Board’s Wrongdoing – GlobeNewswire” with publication date: August 19, 2019.

Exact Sciences Corporation (NASDAQ:EXAS) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Related Posts:

  • No Related Posts